Archit Organosys standalone net profit rises 10.34% in the December 2022 quarter

Archit Organosys standalone net profit rises 17.61% in the March 2022 quarter

The current market cap of the company is Rs78.72cr.

Archit Organosys allots 35 lakh equity shares on conversion of warrants; Stock sheds 2%

Archit Organosys reports standalone net profit of Rs 1.59 crore in the March 2021 quarter

Archit Organosys jumped 7.68% to Rs 50.45 after Standard Greases and Specialities purchased 0.67% stake in the company via bulk deal on Tuesday (8 June).

Archit Organosys extends rally after Standard Greases buys stake

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Archit Organosys is engaged in the business of dealing and manufacturing of chemicals. It's products include Mono Chloco Acetic Acid and Ethyle Acetate